EA
BIIB icon

Edge Advisors’s Biogen BIIB Stock Holding History

Edge Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$101K Sell
350
-69
-16% -$19.4K 0.01% 397
2018
Q1 		$114K Buy
419
+174
+71% +$54K 0.01% 390
2017
Q4 		$77K Sell
245
-62
-20% -$19.9K 0.01% 437
2017
Q3 		$95K Buy
307
+65
+27% +$19.2K 0.01% 393
2017
Q2 		$64K Sell
242
-493
-67% -$130K 0.01% 459
2017
Q1 		$200K Buy
735
+518
+239% +$146K 0.02% 321
2016
Q4 		$61K Buy
+217
New +$64.3K 0.01% 438

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edge Advisors's BIIB Position: Q2 2018 in Review

Edge Advisors reduced its Biogen (BIIB) stake by 16% in Q2 2018, selling an estimated $19.4K and leaving 350 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #397.

Edge Advisors first reported a position in BIIB in Q4 2016 and has held it in 7 quarters since. The position peaked at $200K in Q1 2017. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Edge Advisors held 350 shares of Biogen worth $101K as of Q2 2018.
  • Edge Advisors sold 69 Biogen shares in Q2 2018, an estimated $19.4K.
  • Biogen made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #397 holding.
  • Edge Advisors first reported a position in Biogen in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Biogen position peaked at $200K in Q1 2017.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.